{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:33:48Z","timestamp":1779312828302,"version":"3.51.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To estimate the accuracy of vaginal cytology in postoperative surveillance for detecting recurrent endometrial cancer and to estimate the optimal management of squamous abnormalities detected in this setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This review included women who underwent hysterectomy for endometrial cancer between January 1, 2006, and December 31, 2010, and had at least one postoperative Pap test. Clinical and demographic data were collected and outcomes including abnormal vaginal cytology, results of colposcopic examination, and endometrial cancer recurrence were assessed. A Cox regression model to estimate the risk of abnormal cytology was created. Sensitivity, specificity, and negative and positive predictive values of detecting vaginal recurrences were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Four hundred thirty-three women contributed 2,378 Pap tests. At least one abnormal cytology result was found during follow-up of 55 (13%) women, representing 3% of all Pap tests. No recurrent endometrial cancers were diagnosed on the basis of isolated abnormal cytology. No cases of recurrent cancer were diagnosed in women with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion (LSIL) Pap test results. In multivariable analysis, abnormal cytology was highly associated with prior postoperative radiation therapy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). The sensitivity, specificity, and positive and negative predictive values of an abnormal Pap test result in detecting a local recurrence are 40%, 87.9%, 7.3%, and 98.4%, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Colposcopy is not needed after a Pap test result read as atypical squamous cells of undetermined significance or LSIL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>III<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0b013e31827499a9","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T14:40:27Z","timestamp":1444747227000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["The Utility and Management of Vaginal Cytology After Treatment for Endometrial Cancer"],"prefix":"10.1097","volume":"121","author":[{"given":"Akiva P.","family":"Novetsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay M.","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Stewart","family":"Massad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea R.","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premal H.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Zighelboim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20-20260317","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":". Survival after relapse in patients with endometrial cancer: results from a randomized trial.","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R3-20-20260317","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1525-1438.2007.00858.x","article-title":". Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.","volume":"17","author":"Huh","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20-20260317","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-8140(02)00212-8","article-title":". Outcome after salvage radiotherapy (brachytherapy - external) in patients with a vaginal recurrence from endometrial carcinomas.","volume":"65","author":"Hasbini","year":"2002","journal-title":"Radiother Oncol"},{"key":"R5-20-20260317","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ygyno.2005.11.004","article-title":". Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence.","volume":"101","author":"Petignat","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R6-20-20260317","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer.","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20-20260317","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":". Postsurgical surveillance of patients with FIGO stage III endometrial adenocarcinoma.","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R8-20-20260317","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ijgc-00009577-200409000-00029","article-title":"The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients.","volume":"14","author":"Tjalma","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R9-20-20260317","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":". Follow-up after primary therapy for endometrial cancer: a systematic review.","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R10-20-20260317","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ygyno.2006.05.013","article-title":"Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R11-20-20260317","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2011.07.014","article-title":"Recurrence patterns and surveillance for patients with early stage endometrial cancer.","volume":"123","author":"Salani","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R12-20-20260317","first-page":"71","article-title":"Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer Obstet G","volume":"107","author":"Cooper","year":"2006","journal-title":"ynecol"},{"key":"R14-20-20260317","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"ACOG Practice Bulletin No. 109. American College of Obstetricians and Gynecology.","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R15-20-20260317","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":". The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R16-20-20260317","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/AOG.0b013e31819fe844","article-title":"Factors affecting risk of mortality in women with vaginal cancer.","volume":"113","author":"Shah","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R17-20-20260317","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":". Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"R18-20-20260317","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(77)90091-6","article-title":"An epidemiologic study of cancer of the cervix, vagina, and vulva based on the Third National Cancer Survey in the United States.","volume":"129","author":"Henson","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20-20260317","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJM199611213352103","article-title":"Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease.","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med"},{"key":"R20-20-20260317","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":". Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"R21-20-20260317","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":". Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"R22-20-20260317","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":". Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201301000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:00:18Z","timestamp":1773709218000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201301000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e31827499a9","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}